Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies — Stella

View on ClinicalTrials.gov

Recruiting

Back to Cancer trials

Trial locations(1 site)

Canada

Centre Hospitalier de l'Université de Montréal, Montreal, Quebec

Key details

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment target

~3,600 participants

Started

September 2019

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.